• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
UnitedHealthcare exec talks AI, affordability and member engagement

special purpose acquisition company

Mergers and acquisitions deals consolidation
Providers

Cano Health exploring sale as its cash dwindles, lays off 700

Cano Health is exploring a sale and plans to lay off 700 employees. It also warned that the company may run out of cash in the next 12 months.
Heather Landi Aug 10, 2023 4:46pm
A person holding a smartphone in their hand with screen shot of Babylon Health app

Babylon to go private in deal with AlbaCore Capital Group

Jun 26, 2023 7:30am
Boardroom standoff

Cano Health CEO exits as company aims to turn around business

Jun 16, 2023 5:00pm
money and shares declining

Cano Health separates chairman, CEO roles amid board shakeup

Apr 17, 2023 10:30am
San Francisco storm

JPM23's Health Tech Tidbits: Talkspace's path to profitability

Jan 16, 2023 7:45pm
23andM3 executive ring the Nasdaq opening bell on the day the company goes public

Why data is 23andMe's 'secret power' for drug development

Jan 20, 2022 5:00pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
    • Editorial Advisory Council
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings